Medical News

RSS

MiMedx Group's HydroFix Spine Shield device receives CE Mark

MiMedx Group, Inc. announced today that the Company received the CE Mark for its HydroFix™ Spine Shield device and was certified for design, development, and production of post-surgical adhesion inhibiting barriers.

1 Mar 2010

Palliative care helps improve quality, cut end of life care costs

The Philadelphia Inquirer reports on palliative care and focuses on a fairly typical American hospital in Abington.

1 Mar 2010

Thirty-six organizations urge Congress to pass health reform legislation

State, regional and national public health associations today called on Congress to send comprehensive health reform legislation to the president in the coming weeks. Thirty-six organizations representing tens of thousands of public health professionals from Alaska to Maine, Iowa to Kentucky and states in between signed on to a letter to members of Congress urging action.

1 Mar 2010

First Personal Injury praises HSE's workplace safety campaign

The latest phase of the campaign aims to raise awareness of the potential dangers of trips and falls in the workplace and features some graphic and hard hitting posters. The posters, typically featuring alarming images of workers 'shattering' upon impact following a fall, also feature safety information targeted at reducing such accidents.

1 Mar 2010

Physicians urge Senators to repeal Medicare cuts

The U.S. Senate's failure to act before today's 21 percent Medicare physician payment cut has put seniors at grave risk of reduced access to health care and choice of physician.

1 Mar 2010

Scopolamine drug: A rapid-acting antidepressant for depression symptoms

Conventional antidepressant treatments generally require three to four weeks to become effective, thus the discovery of treatments with a more rapid onset is a major goal of biological psychiatry. The first drug found to produce rapid improvement in mood was the NMDA glutamate receptor antagonist, ketamine.

1 Mar 2010

Groups preparing to fight cutbacks, ready final health overhaul push

A renewed push to pass health care reform in America has lobbyists and interest groups pushing to have their voices heard and heeded as lawmakers prepare the endgame on health reform legislation, The Washington Post reports.

1 Mar 2010

ChemGenex Pharmaceuticals' OMAPRO review: FDA reschedules ODAC meeting to 22 March, 2010

ChemGenex Pharmaceuticals Limited announced today that the U.S. Food and Drug Administration (FDA) has rescheduled the previously postponed Oncologic Drugs Advisory Committee (ODAC) meeting to 22 March 2010.

1 Mar 2010

Medicare cuts to doctors payments go into effect today

Starting today, doctors face a 21 percent cut in their reimbursements from Medicare based on a federal budget law that sets physican payments based on other economic factors. In past years, Congress has routinely waived such cuts. The House passed a bill to again postpone the cuts but a similar attempt in the Senate stalled last week.

1 Mar 2010

While Congress debates, health costs continue steep rise

The New York Times' "Week in Review" section features a story that begins: "Suppose Congress and President Obama fail to overhaul the system now, or just tinker around the edges, or start over, as the Republicans propose. ... Then 'my health care' stays the same, right? Far from it, health policy analysts and economists of nearly every ideological persuasion agree. The unrelenting rise in medical costs is likely to wreak havoc within the system and beyond it. ... Even those families that enjoy generous insurance now are likely to see the cost of those benefits escalate.

1 Mar 2010

Validus Medical Systems introduces bi-directional mobile software solution for hospital systems

Validus Medical Systems, Inc., a privately held healthcare IT firm founded by veteran entrepreneur David Kashtan (Network Alchemy, TGV Software), formally launched its breakthrough bi-directional mobile software solution for hospital systems. The Validus inTouchTM software system was developed by Kashtan, a team of leading physicians, software engineers, cloud computing experts, and network security specialists to improve the quality, safety and efficiency of healthcare.

1 Mar 2010

Amerigroup introduces long-term care program to address complex health concerns

Amerigroup Corporation today announced that its Tennessee health plan began offering long-term care (LTC) services to approximately 4,000 existing middle Tennessee members through the state's TennCare CHOICES in LTC program.

1 Mar 2010

OPA encourages Ontarians to discuss travel-related health questions with their pharmacists

Every spring, thousands of Ontarians embark on vacations and, along with luggage and family members, many bring medication. While your passport and camera may seem like the most important things to remember, ensuring you have a backup supply of your prescription medication should be at the top of your to-do list as well.

1 Mar 2010

3DISC introduces new digital technology for medical professionals

3DISC, an innovative manufacturer of CR solutions, will introduce its new FireCR system to medical professionals at the European Congress of Radiology in Vienna March 4–8, 2010.

1 Mar 2010

McGill University and RI MUHC secure $300,000 CIHR grant to develop VLP vaccines

The Canadian Institutes of Health Research (CIHR) have awarded a $300,000 grant for research focusing on the nature of the immune response induced by the action mechanisms of plant-made Virus-Like Particles (VLP) to Dr. Louis Vezina, Chief Scientific Officer of Medicago and to Dr. Brian Ward and Dr. Ciriaco Piccirillo of the Research Institute of the McGill University Health Centre (RI MUHC) and McGill University.

1 Mar 2010

Isis Pharmaceuticals reports revenues of $32.3M for fourth-quarter 2009

Isis Pharmaceuticals, Inc. today announced its 2009 financial results and reviewed the highlights of the year. Isis achieved its 2009 financial guidance with pro forma net income of $166.9 million and a pro forma net operating loss (NOL) of $14.2 million compared with its guidance for the year of pro forma net income of more than $145 million and a pro forma NOL in the low to mid $20 million range. Isis also achieved its cash guidance by ending 2009 with $574.3 million of cash, cash equivalents and short-term investments significantly in excess of the $550 million projected.

1 Mar 2010

QuadraMed to showcase EHR and Smart Identity Management solutions at HIMSS Interoperability Showcase

QuadraMed® Corporation, a leading provider of healthcare technologies and services that help turn quality care into positive financial outcomes, will demonstrate its award-winning electronic health record (EHR) and Smart Identity Management solutions at the annual Healthcare Information and Management Systems Society (HIMSS) Conference and Exhibition’s Interoperability Showcase. The event takes place March 1-4 at the Georgia World Congress Center in Atlanta.

1 Mar 2010

COMP issues positive opinion for Æterna Zentaris' perifosine orphan medicinal product designation

Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that it has received a positive opinion for orphan medicinal product designation for its compound perifosine from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency, for the treatment of multiple myeloma.

1 Mar 2010

4medica's IHR to be demonstrated at HIMSS conference

4medica, the leading independent provider of Web-based connectivity between physicians and clinical laboratories, today announced the launch of its Integrated Health Record (IHR™), which includes modular components designed to enable hospitals and eligible providers to demonstrate “meaningful use” and qualify for federal government incentives in 2011.

1 Mar 2010

AMAG Pharmaceuticals reports fourth-quarter 2009 net product revenues of $12.8M attributable to Feraheme

AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the fourth quarter and year ended December 31, 2009.

1 Mar 2010